3-phenylpropionic acid has been researched along with Diabetes Mellitus, Adult-Onset in 3 studies
3-phenylpropionic acid: RN given refers to parent cpd
3-phenylpropionic acid : A monocarboxylic acid that is propionic acid substituted at position 3 by a phenyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A novel series of 5-membered heterocycle-containing phenylpropanoic acid derivatives was discovered as potent GPR120 agonists with low clearance, high oral bioavailability and in vivo antidiabetic activity in rodents." | 1.46 | Design, synthesis and SAR of a novel series of heterocyclic phenylpropanoic acids as GPR120 agonists. ( Bell, A; Cai, C; Clapper, W; Gunnet, J; Haug, P; Hua, H; Jenkinson, C; Lanter, J; Leonard, J; Ma, J; Murray, WV; Nashashibi, I; Novack, A; Suckow, A; Sui, Z; Wall, M; Wang, Y; Wells, M; Winters, M; Yan, W; Zhang, X, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Noso, S | 1 |
| Babaya, N | 1 |
| Hiromine, Y | 1 |
| Taketomo, Y | 1 |
| Niwano, F | 1 |
| Yoshida, S | 1 |
| Ikegami, H | 1 |
| Zhang, X | 1 |
| Cai, C | 1 |
| Winters, M | 1 |
| Wells, M | 1 |
| Wall, M | 1 |
| Lanter, J | 1 |
| Sui, Z | 1 |
| Ma, J | 1 |
| Novack, A | 1 |
| Nashashibi, I | 1 |
| Wang, Y | 1 |
| Yan, W | 1 |
| Suckow, A | 1 |
| Hua, H | 1 |
| Bell, A | 1 |
| Haug, P | 1 |
| Clapper, W | 1 |
| Jenkinson, C | 1 |
| Gunnet, J | 1 |
| Leonard, J | 1 |
| Murray, WV | 1 |
| Bahl, JJ | 1 |
| Matsuda, M | 1 |
| DeFronzo, RA | 1 |
| Bressler, R | 1 |
3 other studies available for 3-phenylpropionic acid and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Metabolic signatures of β-cell destruction in type 1 diabetes.
Topics: 5-Methylcytosine; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Hum | 2023 |
Design, synthesis and SAR of a novel series of heterocyclic phenylpropanoic acids as GPR120 agonists.
Topics: Animals; Biological Availability; Blood Glucose; Diabetes Mellitus, Type 2; Drug Design; HEK293 Cell | 2017 |
In vitro and in vivo suppression of gluconeogenesis by inhibition of pyruvate carboxylase.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Gluconeogenesis; Glucose; Hypog | 1997 |